Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
F
Details...
Enter Symbol
Seattle Genetics, Inc. (NASDAQ: SGEN)
Sector: Medical
Current Price :
$34.95
52 Week Low
$18.50
52 Week High
$37.22
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
120M
Market Cap:
$4.45B
Avg Volume:
802107
P/E Ratio:
-0.010
PEG Ratio:
-0.010
1m
3m
6m
1y
2y
Opinion and Analysis
Seattle Genetics (SGEN): FDA Accepts ADCETRIS Supplemental BLA
May 14, 2013 09:41 AM |
SGEN
Seattle Genetics (SGEN) Submits Supplement For Hodgkin Lymphoma Therapy
Mar 18, 2013 01:06 PM |
SGEN
A Spin-Off Stock Every Investor Should Own
Jan 09, 2013 02:45 PM |
ABT
,
GILD
,
MDCO
,
SGEN
More Articles on SGEN..
Press Releases
Free Research Reports on CLX, FDS, SGEN and VAL Issued by the Bedford Report
May 15, 2013 08:15 AM |
CLX
,
FDS
,
SGEN
,
VAL
Seattle Genetics Announces ADCETRIS? (Brentuximab Vedotin) Supplemental BLA Accepted for Filing by the FDA
May 14, 2013 09:00 AM |
SGEN
Seattle Genetics to Present at Upcoming Investor Conferences
May 09, 2013 09:00 AM |
SGEN
More Press Releases on SGEN..
SEC Filings
Form 4 SEATTLE GENETICS INC For: Mar 11 Filed by: DOBMEIER ERIC (10K)
Mar 12, 2013 07:26 PM
Form 4 SEATTLE GENETICS INC For: Mar 07 Filed by: SIMPSON TODD E (10K)
Mar 08, 2013 07:29 PM
Form 4 SEATTLE GENETICS INC For: Mar 04 Filed by: DOBMEIER ERIC (10K)
Mar 06, 2013 07:33 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
SGEN
Compare to S&P
YTD
59.52 %
46.28 %
4 Weeks
2.04 %
2.15 %
12 Weeks
21.98 %
17.88 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
25.00 %
EPS Growth in Last Year:
62.50 %
Sales Growth in Last Quarter:
28.25 %
Sales Growth in Last Quarter:
30.73 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##